Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute, Egypt
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
M.D. Anderson Cancer Center
Stanford University
Mayo Clinic
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
ImmunityBio, Inc.
Immatics US, Inc.
Acepodia Biotech, Inc.
West China Hospital
SCG Cell Therapy Pte. Ltd.
HRYZ Biotech Co.
HRYZ Biotech Co.
Brooklyn ImmunoTherapeutics, LLC
NexImmune Inc.
Dana-Farber Cancer Institute
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
The Affiliated Hospital of Xuzhou Medical University
The Affiliated Hospital of Xuzhou Medical University
CEL-SCI Corporation
Genocea Biosciences, Inc.
Corregene Biotechnology Co., Ltd
Gliknik Inc.
Mie University
Brooklyn ImmunoTherapeutics, LLC
Fujian Cancer Hospital
Gruppo Oncologico del Nord-Ovest
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Emory University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mie University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
National Health Research Institutes, Taiwan
National Cancer Institute (NCI)
Herlev Hospital
University of Yamanashi